Migdal Insurance & Financial Holdings’s PureTech Health PRTC Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio PRTC Stock Details PRTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-233	Closed	-$9K	–	674
2021 Q4	$9K	Sell	233 -140	-38%	-$6.19K	﹤0.01%	611
2021 Q3	$18K	Buy	+373	New	+$18.1K	﹤0.01%	563

Other funds holding PRTC

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Migdal Insurance & Financial Holdings's PRTC Position: Q1 2022 in Review

Migdal Insurance & Financial Holdings sold out of PureTech Health (PRTC) in Q1 2022, closing a stake of 233 shares — an estimated $9K sold.

Migdal Insurance & Financial Holdings first reported a position in PRTC in Q3 2021 and held it in 2 quarters. The position peaked at $18K in Q3 2021. 2 funds tracked by Wall St. Rank hold PRTC as of Q1 2022.

Migdal Insurance & Financial Holdings reported no remaining PureTech Health position as of Q1 2022 after selling out during the quarter.
Migdal Insurance & Financial Holdings sold 233 PureTech Health shares in Q1 2022, an estimated $9K.
Migdal Insurance & Financial Holdings first reported a position in PureTech Health in Q3 2021 and held it in 2 quarters.
Migdal Insurance & Financial Holdings's PureTech Health position peaked at $18K in Q3 2021.
2 funds tracked by Wall St. Rank held PureTech Health as of Q1 2022.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2022, filed 2 May 2022.